GEODE CAPITAL MANAGEMENT, LLC
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in ZNTL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,453,223
+$657,932 QoQ
Shares Held
621,036
+5.4% QoQ
Ownership
0.872%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. ZNTL ranks #292 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in ZNTL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,453,223 | 621,036 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $795,291 | 589,105 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $889,724 | 589,222 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $717,073 | 618,167 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,155,513 | 1,355,669 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,978,280 | 1,312,964 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,754,927 | 1,292,100 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $5,457,936 | 1,334,459 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $20,523,255 | 1,302,237 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $18,994,115 | 1,253,737 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $23,807,950 | 1,186,837 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $30,117,024 | 1,067,601 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,409,910 | 895,925 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $17,264,350 | 857,217 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,112,308 | 836,210 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $21,958,576 | 781,444 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $30,732,192 | 666,064 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $55,581,396 | 661,211 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $42,826,462 | 642,654 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $23,608,298 | 443,765 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $15,917,187 | 366,840 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $17,233,120 | 331,789 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,931,502 | 181,447 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,795,326 | 162,335 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||